Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 8 de 8
Filter
Add more filters










Database
Language
Publication year range
1.
Arch Dermatol Res ; 313(9): 793-797, 2021 Nov.
Article in English | MEDLINE | ID: mdl-33433713

ABSTRACT

Since dermatologists routinely perform surgery in an outpatient setting, ensuring that dermatology trainees are provided with opportunities to develop sufficient proficiency in excisional surgery and suture technique is paramount. The objectives of this study are to assess trainee preference for silicone-based synthetic skin compared with porcine skin as a surgical training medium and to assess the ability of trainees to successfully demonstrate basic surgical skills using the simulated skin model. Participants were a convenience sample of dermatology residents from the greater Chicago area, who were asked to perform an elliptical excision and bilayered repair on a silicone-based synthetic skin model. Residents were then surveyed regarding their satisfaction with the model. Four blinded dermatologist raters evaluated digital photographs obtained during the performance of the procedures and graded the execution of each maneuver using a surgical task checklist. Nineteen residents were enrolled. Residents were more likely to prefer pig skin to simulated skin for overall use (p = 0.040) and tissue repair (p = 0.018), but the nominal preference for tissue handling was nonsignificant (p = 0.086). There was no significant difference between satisfaction with pig skin versus synthetic skin with regard to excision experience (p = 0.82). The majority of residents (10/19) performed all surgical checklist tasks correctly. Of those residents who did not perform all steps correctly, many had difficulty obtaining adequate dermal eversion and wound approximation. Synthetic skin may be conveniently and safely utilized for hands-on surgical practice. Further refinement may be necessary to make synthetic skin comparable in feel and use to animal skin.


Subject(s)
Ambulatory Surgical Procedures/education , Dermatologic Surgical Procedures/education , Simulation Training/methods , Suture Techniques/education , Ambulatory Surgical Procedures/methods , Animals , Clinical Competence , Dermatologic Surgical Procedures/methods , Dermatology/education , Dermatology/methods , Humans , Internship and Residency , Skin , Skin, Artificial , Surgeons/education , Surgeons/statistics & numerical data , Surveys and Questionnaires/statistics & numerical data , Swine
3.
Dermatol Surg ; 45(6): 768-771, 2019 06.
Article in English | MEDLINE | ID: mdl-30640769

ABSTRACT

BACKGROUND: The Mohs histotechnologist (MH) performs tissue preparation, sectioning, and staining, which are critical tasks in ensuring a successful Mohs micrographic surgery (MMS). OBJECTIVE: To assess current norms in MH training, practice setting, and utilization of specific histologic techniques. MATERIALS AND METHODS: A 16-question survey was created and distributed using Survey Monkey to all members of the American Society for Mohs Histotechnology. RESULTS: Response rate was 30%. Most MHs received on-the-job training from other MHs or the Mohs surgeon. Mohs histotechnologists largely performed tasks related to tissue processing while Mohs surgeons generally illustrated the Mohs layer map. Automated routine staining was used in most laboratory tests, and laboratory tests used similar staining techniques. Most respondents worked in private offices verses academic centers. Total staining time was significantly longer at academic medical centers versus private offices (7 vs 5 minutes, p = .01). CONCLUSION: These findings provide an updated profile of current laboratory training and tissue preparation techniques at MMS practices across the country. Understanding the roles of the MH in laboratory functioning may help laboratories adopt best practices.


Subject(s)
Histological Techniques/methods , Mohs Surgery/methods , Skin Neoplasms/pathology , Skin Neoplasms/surgery , Education, Professional , Histocytological Preparation Techniques/methods , Humans , Patient Care Team , Professional Role , Surveys and Questionnaires
5.
J Cosmet Laser Ther ; 18(4): 225-9, 2016 Aug.
Article in English | MEDLINE | ID: mdl-27077529

ABSTRACT

BACKGROUND: Scarring following skin surgery is an unavoidable certainty. Scars resulting from Mohs Micrographic Surgery (MMS) can cause both cosmetic and functional problems. Various lasers have been used to treat scars, but the role of the microsecond pulsed 1064 nanometer neodymium-doped yttrium aluminum garnet (1064 nm Nd:YAG) in treating surgical scars is not well-defined. OBJECTIVE: We aim to examine the clinical application of the 1064 nm Nd:YAG laser in improving surgical scars. METHODS: Ten patients who were unhappy with cosmetic or functional outcomes of their surgical scars following MMS were treated with 1-3 sessions of the 1064 nm Nd:YAG laser to improve their scars. Therapy completion was determined by patient satisfaction with the appearance of their scars and/or resolution of any contractures that formed following surgery. RESULTS: All ten patients were pleased with the improved appearance of their scars. Four patients saw complete resolution of an ectropion or eclabium that formed secondary to scar contractures from MMS. The side effects of laser treatments were limited to 1-2 hours of erythema, and there were no incidences of adverse effects or recurrence of contractures. CONCLUSION: Our clinical experience with the 1064 nm Nd:YAG laser provides promising data on improving appearance of and functionality from post-surgical scars.


Subject(s)
Cicatrix/radiotherapy , Lasers, Dye/therapeutic use , Lasers, Gas/therapeutic use , Low-Level Light Therapy/methods , Mohs Surgery/adverse effects , Adult , Cicatrix/etiology , Cosmetic Techniques , Female , Humans , Male , Treatment Outcome
7.
Cytokine ; 73(2): 319-25, 2015 Jun.
Article in English | MEDLINE | ID: mdl-25541432

ABSTRACT

Much work has been done to unveil the mechanisms behind the pathogenesis of dermatomyositis (DM) - mainly those involving certain pathogenic cytokines, termed "pathokines" as the principal cytokines involved. Recently, it has become clear that a group of cytokines known as type I interferons (IFN-Is) play a significant role in the development of DM. We review the literature published between 1946 and 2014 using an Ovid Medline database search to provide an update on the role of IFN-Is and other cytokines in the pathogenesis of DM. We provide information about the genes and proteins induced by IFN-Is and potential mechanisms by which these downstream products relate to clinical disease activity. We also explore findings of other autoimmune phenomena that may contribute to disease onset and activity including T-helper 17 (Th17) cells and associated interleukins, as well as autoantibodies. Finally, we provide a brief update on current treatment options for DM as well as some new immunomodulatory treatment modalities in development.


Subject(s)
Dermatomyositis/immunology , Interferon Type I/metabolism , Autoantibodies/immunology , Dermatomyositis/physiopathology , Dermatomyositis/therapy , Humans , Models, Biological , Signal Transduction
SELECTION OF CITATIONS
SEARCH DETAIL
...